Global Early Warning

Deploy pathogen-agnostic surveillance that can identify any pathogen before it spreads widely.

Last updated: May 11, 2026 · Public updates are batched quarterly, with urgent corrections as needed.

5-year budget target

$250M

Pillar

Detect

Five-Year Trajectory

2026

Deploy pathogen-agnostic detection at 20+ sentinel sites with predefined triggers, decision rights, and response personnel

2027

Complete first-wave sentinel deployment and integrate anomaly-detection, investigation, and response workflows

2028

Scale pathogen-agnostic surveillance and signal-to-action workflows to major hubs and sentinel sites on six continents

2029

Reach 50+ travel hubs and municipalities with pathogen-agnostic surveillance linked to response activation

2030

Sustain and refine the global pathogen-agnostic surveillance and response-trigger architecture

Current Status of the Field

Technology

Metagenomic sequencing, wastewater testing, air sampling, pooled clinical sampling, serology, and syndromic analytics are all advancing, but they are usually deployed as separate systems.

Policy

International data-sharing norms and public-health escalation protocols are improving, but few jurisdictions have predefined decision rights for pathogen-agnostic anomaly signals.

Bottleneck

The bottleneck is operational translation: surveillance must connect to personnel, triggers, verification workflows, and response authorities rather than only producing interesting data.

The Problem

If a novel, transmissible pathogen were released today, we would likely fail to detect it until it had already spread widely. Current biosurveillance systems are heavily oriented toward known pathogens or symptomatic populations and are not designed to identify truly novel threats quickly enough. Even when unusual signals appear, they often do not map cleanly to predefined triggers, decision rights, trained personnel, or response playbooks, which means detection can fail to produce action.

The Solution

A robust early-warning system will ultimately require layered syndromic, indicator-based, sentinel, and population-based approaches. Many of the core technologies — including deep sequencing, metagenomics, air sampling, wastewater sampling, pooled clinical sampling, serology, and AI-supported anomaly detection — are already available. The urgent priority is to begin deploying pathogen-agnostic surveillance at sentinel sites with global relevance while linking each signal type to investigation triggers, decision rights, staffing, and response playbooks. Over time, this should mature into an architecture with rapid international data sharing, strong pooled clinical, wastewater, air, and serological surveillance, and the ability for major jurisdictions to stand up sensitive detection and monitoring systems within days of identifying a credible threat.

Objectives

◆Any novel, rapidly spreading pathogen is detected months before most of the world would become infected
◆Pathogen-agnostic surveillance operates continuously at major airports and municipal wastewater facilities on six continents, with international data sharing within 24 hours
◆Top commercial laboratories globally implement pooled, pathogen-agnostic clinical surveillance
◆Syndromic and indicator-based surveillance are integrated with pathogen-agnostic sampling so unusual clinical, operational, or mortality signals can trigger investigation even before sequencing confirmation
◆Major jurisdictions in all regions are capable of implementing sensitive pathogen detection and monitoring via genetic sequencing, PCR, or other techniques within a week of identifying a threat
◆Public health authorities implement serology-based pathogen detection at national scales
◆Public health authorities link surveillance signals to predefined triggers, decision rights, trained personnel, and response playbooks so anomalies translate into action rather than shelfware
◆Vector and animal-reservoir surveillance is operating in priority regions, monitoring mosquitoes, ticks, bats, and other reservoirs for spillover-risk pathogens before they reach humans

Urgent 2026 Milestone

Deploy pathogen-agnostic detection at more than 20 sentinel sites globally, including major transit hubs on at least three continents, with predefined anomaly triggers, decision rights, and response personnel.

Long-term Targets

Pathogen-agnostic early-warning coverage

20+ sites by end of 2027; 50+ by 2029

Detection threshold

<0.01% of global population infected before detection by 2029

Year-by-Year

2026 — Build the foundation

Philanthropy

•Fund pilot deployment of metagenomic sequencing at 20+ sentinel sites internationally, including wastewater, air, and pooled clinical sampling modalities
•Fund development of AI anomaly-detection systems for pooled surveillance data
•Fund design of trigger thresholds, decision rights, staffing models, and escalation playbooks for surveillance signals
•Fund advances in detection technology and bioinformatics to enable affordable pathogen-agnostic surveillance

Private Sector

•Develop, optimize, and deploy metagenomic sequencing platforms for wastewater, air, clinical, and environmental samples
•Build interoperable data platforms for surveillance data sharing
•Build AI-driven metagenomic, syndromic, and indicator-based analysis tools that route anomalies into public-health workflows

Government

•Fund pathogen-agnostic surveillance at airports, pooled clinical systems, and municipal wastewater sites
•Build data pipelines integrating wastewater, air, clinical, syndromic, serology, environmental, and indicator-based surveillance
•Develop and exercise anomaly investigation, verification, response protocols, and named decision rights
•Enhance international data-sharing protocols, with the long-term aim of sharing relevant surveillance data within 24 hours

2027 — Pilots into Operating SystemsDetect-level actions

Philanthropy

•Support completion and operationalization of the first wave of pathogen-agnostic sentinel systems
•Fund workflow optimization and AI anomaly-detection integration across metagenomic, syndromic, and indicator-based signals
•Support exercises to validate anomaly review and escalation processes

Private Sector

•Operate and refine first-wave sequencing and surveillance platforms
•Integrate anomaly-detection tools into routine workflows with clear escalation paths to public-health authorities
•Improve automation and data interoperability for faster analysis

Government

•Complete first-wave deployment of sentinel systems in priority sites
•Integrate anomaly-detection, syndromic, and indicator-based tools into public-health workflows with named decision owners
•Exercise investigation, verification, and response protocols

2028 — Scale and enforceDetect-level actions

Philanthropy

•Support global scale-up of metagenomic surveillance to major travel hubs and sentinel sites on six continents
•Fund exercises to validate end-to-end detection capability from signal to decision to response
•Support development of a global detection architecture capable of identifying novel rapidly spreading pathogens within 30 days

Private Sector

•Operate and maintain surveillance infrastructure at larger scale
•Continue improving analysis tools, interoperability, and real-time detection workflows

Government

•Scale pathogen-agnostic surveillance to major transit hubs and ports of entry
•Build stronger international data-sharing and information-exchange mechanisms with predefined decision rights
•Continue exercising rapid anomaly investigation and response systems from surveillance trigger to action

2029 — Achieve durable readinessDetect-level actions

Philanthropy

•Support final scale-up and validation of the global early-warning architecture
•Fund exercises that test performance under engineered-pathogen scenarios and other edge cases

Private Sector

•Maintain high-quality surveillance infrastructure and rapid data-sharing workflows at scale
•Continue improving analysis speed, anomaly classification, and operational resilience

Government

•Reach or exceed coverage goals for major travel hubs and municipalities
•Maintain rapid anomaly confirmation and response activation capability with named authorities and trained personnel
•Exercise engineered-pathogen detection and response scenarios regularly

2030 — Maintain defensive advantageDetect-level actions

Philanthropy

•Support maintenance, refinement, and targeted expansion of the global early-warning architecture

Private Sector

•Maintain and improve surveillance infrastructure, analysis tools, and data-sharing systems

Government

•Sustain high-coverage pathogen-agnostic surveillance and rapid response capability, with predefined triggers, decision rights, and continued international coordination